Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88310367 |
LAW OFFICE ASSIGNED |
LAW OFFICE 107 |
MARK SECTION |
MARK |
VIRASHIELD (see, http://uspto.report/TM/88310367/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
VIRASHIELD |
OWNER SECTION (current) |
NAME |
GlaxoSmithKline Consumer Healthcare (UK) IP Limited |
MAILING ADDRESS |
980 Great West Road |
CITY |
Brentford, Middlesex |
ZIP/POSTAL CODE |
TW89GS |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United Kingdom |
EMAIL |
XXXX |
OWNER SECTION (proposed) |
NAME |
GlaxoSmithKline Consumer Healthcare (UK) IP Limited |
MAILING ADDRESS |
980 Great West Road |
CITY |
Brentford, Middlesex |
ZIP/POSTAL CODE |
TW89GS |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United Kingdom |
EMAIL |
XXXX |
ATTORNEY INFORMATION (current) |
NAME |
Terence A. Dixon |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
FIRM NAME |
GSK |
INTERNAL ADDRESS |
LBP - NY0300 |
STREET |
5 CRESENT DRIVE |
CITY |
PHILADELPHIA |
STATE |
Pennsylvania |
POSTAL CODE |
19112 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
484-885-9127 |
EMAIL |
trademarks@gsk.com |
DOCKET/REFERENCE NUMBER |
82770362 |
ATTORNEY INFORMATION (proposed) |
NAME |
Terence A. Dixon |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
GSK |
INTERNAL ADDRESS |
LBP - NY0300 |
STREET |
5 CRESENT DRIVE |
CITY |
PHILADELPHIA |
STATE |
Pennsylvania |
POSTAL CODE |
19112 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
484-885-9127 |
EMAIL |
trademarks@gsk.com |
DOCKET/REFERENCE NUMBER |
82770362 |
OTHER APPOINTED ATTORNEY |
Christopher M Hanes, Merilee Arevalo, Michele A. Farber |
CORRESPONDENCE INFORMATION (current) |
NAME |
TERENCE A. DIXON |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
trademarks@gsk.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Terence A. Dixon |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
trademarks@gsk.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
82770362 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceuticals, namely, topical anti-inflammatory and anti-viral preparations for humans |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
09/24/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/tad/ |
SIGNATORY'S NAME |
Terence A. Dixon |
SIGNATORY'S POSITION |
Trademark Counsel, GSK, New York and Pennsylvania |
DATE SIGNED |
03/03/2020 |
SIGNATORY'S PHONE NUMBER |
484-885-9127 |
FILING INFORMATION |
SUBMIT DATE |
Tue Mar 03 13:05:39 ET 2020 |
TEAS STAMP |
USPTO/ESU-XXX.XX.XX.X-202
00303130539177204-8831036
7-710cf4035bdf9e56e2b71b6
8e9ab429246f4a4d38ce992d9
353acf038f1ce8481dd-DA-05
383561-202003030944330645
36 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: VIRASHIELD (see, http://uspto.report/TM/88310367/mark.png)
SERIAL NUMBER: 88310367
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: GlaxoSmithKline Consumer Healthcare (UK) IP Limited, having an address of
980 Great West Road
Brentford, Middlesex, TW89GS
United Kingdom
Email: XXXX
Proposed: GlaxoSmithKline Consumer Healthcare (UK) IP Limited, having an address of
980 Great West Road
Brentford, Middlesex, TW89GS
United Kingdom
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 09/24/2019.
For International Class 005:
Current identification: Pharmaceuticals, namely, topical anti-inflammatory and anti-viral preparations for humans
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
The applicant's current Attorney Information:
Terence A. Dixon GSK
LBP - NY0300
5 CRESENT DRIVE
PHILADELPHIA, Pennsylvania 19112
United States
Phone: 484-885-9127
The docket/reference number is 82770362
Email: trademarks@gsk.com
The applicant's proposed Attorney Information:
Terence A. Dixon GSK
LBP - NY0300
5 CRESENT DRIVE
PHILADELPHIA, Pennsylvania 19112
United States
Phone: 484-885-9127
The docket/reference number is 82770362
Email: trademarks@gsk.com
Correspondence Information (current):
TERENCE A. DIXON
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Terence A. Dixon
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /tad/ Date Signed: 03/03/2020
Signatory's Name: Terence A. Dixon
Signatory's Position: Trademark Counsel, GSK, New York and Pennsylvania
Signatory's Phone: 484-885-9127
Mailing Address:
GSK
LBP - NY0300
5 CRESENT DRIVE
PHILADELPHIA, Pennsylvania 19112
RAM Sale Number: 88310367
RAM Accounting Date: 03/03/2020
Serial Number: 88310367
Internet Transmission Date: Tue Mar 03 13:05:39 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XX.XX.X-202003031305391772
04-88310367-710cf4035bdf9e56e2b71b68e9ab
429246f4a4d38ce992d9353acf038f1ce8481dd-
DA-05383561-20200303094433064536